healthcare innovation India – The Milli Chronicle

Saturday, December 13, 2025

Latest:

Saudi Arabia Strengthens Local Pharma Innovation with Riyadh Generic Drugs Conference 2025
Saudi Arabia Rises in Global Universal Health Coverage Index with Strong Vision 2030 Reforms
Global Harmony Takes Center Stage as China’s Chorus Choir Debuts in Saudi Arabia
Lululemon CEO exit sparks optimism for brand reset and renewed growth
US regulator grants initial approval for major crypto firms to launch national trust banks

Factual Version of a Story

NewsDesk Milli Chronicle December 12, 2025December 12, 2025 affordable semaglutide, chronic disease management, diabetes drug pricing, diabetes treatment India, glycemic control therapy, healthcare innovation India, heart health medication, India healthcare growth, India obesity care, Indian pharmaceutical market, kidney risk reduction drug, metabolic drug competition, metabolic health market, Novo Nordisk India, obesity treatment trends, Ozempic India launch, semaglutide generics, type 2 diabetes population, weekly diabetes injection, weight loss treatment India

Ozempic Debuts in India as Affordable Weekly Option for Growing Diabetes Care

Ozempic made its highly anticipated entry into the Indian market with pricing designed to improve access for millions managing type

Novo Nordisk Slashes Wegovy Price in India, Boosting Access to Weight-Loss Treatments Nationwide

The Danish pharmaceutical giant’s price reduction for Wegovy marks a major step toward making innovative weight-loss and diabetes care more

Asia Latest News

NewsDesk Milli Chronicle November 4, 2025 complex biological drugs India, contract drug manufacturing, healthcare infrastructure India, healthcare innovation India, India healthcare sector growth, medical technology investment, Novo Holdings India investments, Novo Nordisk Foundation investments, senior care investment, single-specialty hospitals in India, step-down care India

Novo Holdings strengthens India focus with bigger investments in niche healthcare sectors

Hyderabad – Global investment powerhouse Novo Holdings is deepening its presence in India with major investments in single-specialty hospitals, advanced

Asia Latest News

NewsDesk Milli Chronicle October 6, 2025October 6, 2025 Alzheimer’s drug India, autoimmune medication India, biotech jobs India, cancer treatment India, contract manufacturing India, diabetes medication India, Eli Lilly investment India, global drug supply, healthcare innovation India, Hyderabad manufacturing facility, Mounjaro launch India, obesity treatment India, pharma industry growth India, pharmaceutical manufacturing India, skilled workforce India.

Eli Lilly Commits Over $1 Billion to Expand Manufacturing and Healthcare Innovation in India

Bengaluru – Eli Lilly announces major investment in India to boost drug manufacturing, create jobs, and enhance patient access to